Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on October 12, 2012, reporting events occurring on October 10, 2012. The registrant, Lexaria Corp. (also referred to as Lexaria Bioscience Corp.), is a Nevada corporation headquartered in Vancouver, British Columbia. The filing serves as a Regulation FD disclosure regarding operational updates.
Key Financial Metrics
The filing does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity figures. The only quantitative data provided relates to operational output:
- Oil Production: Approximately 43,742 barrels produced from the Belmont Lake Oil Field between November 1, 2011, and October 8, 2012.
Material Changes
The company announced that the Belmont Lake Oil Field continues to perform strongly. No comparative production data for the prior period is included in this specific filing text to quantify the change.
Outlook, Risks, and Management Commentary
Management commentary is limited to the positive performance of the Belmont Lake well. The filing incorporates a news release (Exhibit 99.1) for further details but does not explicitly state future guidance, specific risks, contingencies, or unusual items within the body of this report.
Investor Verification Checklist
- Verify the full text of the news release filed as Exhibit 99.1 for detailed production metrics and context.
- Confirm the current operational status of the Belmont Lake Oil Field post-October 2012.
- Review subsequent filings for financial impact of the reported oil production on revenue and cash flow.
- Check for any updates regarding the company's name usage (Lexaria Corp. vs. Lexaria Bioscience Corp.).